• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[干扰素综述:五十年后(1957 - 2007)]

[A review of interferons: fifty years later (1957-2007)].

作者信息

Ramos-Bello Dolores, Ramos-Niembro Francisco

机构信息

Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, NL, México.

出版信息

Gac Med Mex. 2008 Jan-Feb;144(1):55-65.

PMID:18619059
Abstract

Initially identified as a defense mechanism against viral infections, in the last 50 years interferons have been defined a group of substances belonging to the cytokine family indispensable for the normal functioning of the immune system. Derived from their pleiotropic functions interferons were the first biological products used to treat several diseases. Their properties have progressively placed them as the first treatment choice for chronic infection with hepatitis B virus, hepatitis C virus, multiple sclerosis, some forms of leukemia, melanoma, etc. It has been noted however that the administration of supra physiological doses of interferons with therapeutic objectives, independently of its primary indication, has been associated with significant toxicity, including autoimmunity and induction of more than thirty different autoimmune diseases.

摘要

最初被确定为一种针对病毒感染的防御机制,在过去50年里,干扰素已被定义为一组属于细胞因子家族的物质,对免疫系统的正常运作不可或缺。由于其多效性功能,干扰素是最早用于治疗多种疾病的生物制品。它们的特性逐渐使它们成为治疗乙型肝炎病毒、丙型肝炎病毒慢性感染、多发性硬化症、某些形式的白血病、黑色素瘤等疾病的首选治疗方法。然而,已经注意到,出于治疗目的给予超生理剂量的干扰素,无论其主要适应症如何,都与显著的毒性有关,包括自身免疫以及诱发三十多种不同的自身免疫性疾病。

相似文献

1
[A review of interferons: fifty years later (1957-2007)].[干扰素综述:五十年后(1957 - 2007)]
Gac Med Mex. 2008 Jan-Feb;144(1):55-65.
2
Interference by interferons: Janus faces in vascular proliferative diseases.干扰素的干扰作用:血管增殖性疾病中的双面性
Cardiovasc Res. 2005 Jun 1;66(3):433-43. doi: 10.1016/j.cardiores.2005.03.013.
3
[Interferon system in viral hepatitis].[病毒性肝炎中的干扰素系统]
Rev Invest Clin. 1990 Jul;42 Suppl:92-6.
4
Interferon modulates central nervous system function.干扰素调节中枢神经系统功能。
Brain Res. 2012 Mar 9;1442:76-89. doi: 10.1016/j.brainres.2011.09.061. Epub 2011 Oct 8.
5
Role of interferon in clinical practice.干扰素在临床实践中的作用。
Ther Hung. 1991;39(4):159-66.
6
[Interferons: structure, functions and therapeutic applications].[干扰素:结构、功能及治疗应用]
J Chir (Paris). 1994 Aug-Sep;131(8-9):381-90.
7
[Therapeutic use of interferons and their toxicity. Focus on peripheral neuropathy].[干扰素的治疗用途及其毒性。重点关注周围神经病变]
Recenti Prog Med. 2007 Jun;98(6):329-34.
8
[Interferons. Structure, functions and therapeutic applications of interferons].[干扰素。干扰素的结构、功能及治疗应用]
Ann Med Interne (Paris). 1993;144(8):539-47.
9
Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.用于治疗慢性乙型肝炎、丙型肝炎和人类免疫缺陷病毒感染的抗病毒联合疗法。
Handb Exp Pharmacol. 2009(189):321-46. doi: 10.1007/978-3-540-79086-0_12.
10
Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.慢性丙型肝炎患者基因多态性与干扰素诱导的血液学不良反应的关联
J Viral Hepat. 2009 Jun;16(6):388-96. doi: 10.1111/j.1365-2893.2009.01095.x. Epub 2009 Feb 5.

引用本文的文献

1
Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial.共识干扰素治疗HbeAg阳性慢性乙型肝炎的疗效:一项多中心随机对照试验。
Virol J. 2009 Jul 9;6:99. doi: 10.1186/1743-422X-6-99.